TigaTX
Aaron Nelson - Director
Oncology, Immunology
Boston, USA
TigaTX is developing an IgA therapeutic monoclonal antibody platform to activate neutrophils for the treatment of solid tumors.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.